Next week, massive premium increases get locked in. The GOP has shown no interest in stopping it, or preventing any other increases in health care costs.
PBMs
Meet the Connectors
Middlemen, our economy’s most shadowy characters, sit in between buyers and sellers and get rich in the process. It can even be a matter of life or death.
UnitedHealth Has 2,694 Subsidiaries and Affiliates. Is It Too Big to Manage?
This behemoth conglomerate might just be too monstrous for its own good.
Trump’s Order to Cut Drug Prices Would Raise Drug Prices
The so-called ‘pill penalty’ fix is a corporate favor designed to increase the period where prescriptions are immune from price negotiations.
The Case Without a Judge
The logical, absurd end point of Donald Trump’s government smash-and-grab
UnitedHealth’s K Street Army
The health care conglomerate keeps former Hakeem Jeffries staffers and a Trump White House aide on its payroll.
The Government Is Shutting Down Because Elon Musk Has Factories in China
There’s a mundane reason for the late-term chaos, and it’s called a conflict of interest.
Congressional Drug-Pricing Reforms Upend Trump’s Strategy
He has typically allied with Big Pharma, pointing fingers at pharmacy benefit managers. But a bipartisan agreement could do away with that gambit.
Crypto-Backed California Republican Attacks Opponent for Owning Crypto
It’s part of a Vietnamese-language red-baiting campaign by Rep. Michelle Steel, who faces a stiff challenge in California’s 45th Congressional District against veteran and pharmacy owner Derek Tran.
The Prospect Weekly Roundup: Every News Story That’s Happened This Week
David Dayen and Maureen Tkacik try their best to get through all of them.

